FVCB:NASDAQFVCBankcorp, Inc. Analysis
Data as of 2026-05-20 - not real-time
$15.41
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
FVCBankcorp trades at $15.41, well below its DCF‑derived fair value of $35.10, representing an upside of roughly 19% based on the model. The stock’s price‑to‑earnings multiple of 12x is comfortably under the industry average of 16.5x, and the price‑to‑book ratio of 1.07 suggests it is trading close to book value. Revenue is expanding at a solid 16.7% year‑over‑year, while earnings per share are expected to rise from $1.28 trailing to $1.60 forward, underscoring a healthy growth trajectory. The dividend yield of 1.82% is supported by a modest 14% payout ratio and a cash pile of $193 M against $32 M of debt, indicating strong dividend sustainability. Technicals show the price sitting just above the 20‑day SMA (15.63) and comfortably above the 200‑day SMA (14.02), with the 20‑day SMA still above the 50‑day SMA, signaling a bullish bias, though the MACD histogram is negative and the RSI sits at 46, suggesting short‑term caution. Recent news highlights a 24% jump in Q1 net income to $6.4 M and the opening of a new loan production office in Virginia Beach, pointing to continued operational expansion.
Overall, the combination of deep valuation discounts, accelerating earnings, low leverage, and a stable dividend makes FVCBankcorp an attractive candidate for investors seeking both value and modest growth. The stock’s beta of 0.36 and 30‑day volatility of 13.8% indicate limited price swings relative to the market, while stable trading volumes provide adequate liquidity. Given the bullish trend direction and supportive fundamentals, the outlook is positive across medium and long horizons, with a more cautious stance for the immediate term.
Overall, the combination of deep valuation discounts, accelerating earnings, low leverage, and a stable dividend makes FVCBankcorp an attractive candidate for investors seeking both value and modest growth. The stock’s beta of 0.36 and 30‑day volatility of 13.8% indicate limited price swings relative to the market, while stable trading volumes provide adequate liquidity. Given the bullish trend direction and supportive fundamentals, the outlook is positive across medium and long horizons, with a more cautious stance for the immediate term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering near the $15.25 support level
- Negative MACD histogram indicating short‑term momentum weakness
- Bullish trend direction and stable volume provide a defensive cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to DCF fair value and industry PE
- Strong revenue growth (16.7%) and improving EPS outlook
- Sustainable dividend with low payout ratio and ample cash
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Robust balance sheet with low debt and high cash reserves
- Continued expansion evidenced by new loan office and rising net income
- Low beta and moderate volatility suggest defensive stability over time
Key Metrics & Analysis
Financial Health
Revenue Growth16.70%
Profit Margin34.03%
P/E Ratio12.0
ROE9.26%
ROA1.02%
P/B Ratio1.1
Op. Cash Flow$26.1M
Industry P/E16.5
Technical Analysis
TrendBullish
RSI46.3
Support$15.25
Resistance$18.41
MA 20$15.63
MA 50$15.33
MA 200$14.02
MACDBearish
VolumeStable
Fear & Greed Index89.34
Valuation
Fair Value$35.10
Target Price$18.38
Upside/Downside19.24%
GradeUndervalued
TypeBlend
Dividend Yield1.82%
Risk Assessment
Beta0.70
Volatility13.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.